Studies have shown that SQSTM1 mutations can result in complex neurological presentations, ranging from ALS and FTD to myopathy and sensorimotor neuropathy, expanding the gene's phenotypic range [6,9,14]. This evidence concerns the gene SQSTM1 and myopathy.